Bellerophon Therapeutics BLPH
$ 0.1
-74.18%
Quarterly report 2023-Q3
added 11-14-2023
Country |
USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Fabian Tenenbaum |
Employees in the company |
18 |
Shares |
9.55 M |
Market Cap[1] |
$ 955 K |
EBITDA (LTM) |
$ -11.1 M |
P/E (LTM) |
-0.12 |
P/S (LTM) |
- |
EPS (LTM) |
-0.84 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.